The association between olfactory impairment and total mortality in older adults

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 2, 2012, Pages 204-209

  Gopinath, Bamini ^a   Sue, Carolyn M ^b   Kifley, Annette ^a   Mitchell, Paul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Blue Mountains Eye Study; Cognitive impairment; Mortality; Older adults; Olfactory impairment

Indexed keywords

AGE; AGED; AGING; ARTICLE; AUSTRALIA; CAUSE OF DEATH; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; MORTALITY; ODOR; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SMELLING DISORDER; SURVIVAL RATE; TIME;

AGE FACTORS; AGED; AGING; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; OLFACTION DISORDERS; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMELL; SURVIVAL RATE; TIME FACTORS;

EID: 84856184047     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr165     Document Type: Article

References (37)

1. Mackay-Sim A, Johnston AN, Owen C, Burne TH. Olfactory ability in the healthy population: reassessing presbyosmia. Chem Senses. 2006;31:763-771. (Pubitemid 44530680)
2. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002;288:2307-2312. (Pubitemid 35291761)
3. Karpa MJ, Gopinath B, Rochtchina E, et al. Prevalence and neurodegenerative or other associations with olfactory impairment in an older community. J Aging Health. 2010;22:154-168.
4. Bramerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: the skovde population-based study. Laryngoscope. 2004;114:733-737. (Pubitemid 38548788)
5. Seo HS, Jeon KJ, Hummel T, Min BC. Influences of olfactory impairment on depression, cognitive performance, and quality of life in Korean elderly. Eur Arch Otorhinolaryngol. 2009;266:1739-1745.
6. Boyce JM, Shone GR. Effects of ageing on smell and taste. Postgrad Med J. 2006;82:239-241.
7. Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg. 2001;127:497-503. (Pubitemid 32434044)
8. Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991;117:519-528.
9. Smeets MA, Veldhuizen MG, Galle S, et al. Sense of smell disorder and health-related quality of life. Rehabil Psychol. 2009;54:404-412.
10. Pause BM, Miranda A, Goder R, Aldenhoff JB, Ferstl R. Reduced olfactory performance in patients with major depression. J Psychiatr Res. 2001;35:271-277. (Pubitemid 32928428)
11. Pollatos O, Albrecht J, Kopietz R, et al. Reduced olfactory sensitivity in subjects with depressive symptoms. J Affect Disord. 2007;102:101-108. (Pubitemid 47042179)
12. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord. 2003;18:364-372. (Pubitemid 36527276)
13. Nordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol B Psychol Sci Soc Sci. 1995;50:187-192.
14. Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. J Alzheimers Dis. 2005;7:149-157. (Pubitemid 40592189)
15. Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc. 2008;56:1517-1521.
16. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol. 2008;63:167-173. (Pubitemid 351355295)
17. Sobel N, Thomason ME, Stappen I, et al. An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proc Natl Acad Sci U S A. 2001;98:4154-4159. (Pubitemid 32249914)
18. Weinstock RS, Wright HN, Smith DU. Olfactory dysfunction in diabetes mellitus. Physiol Behav. 1993;53:17-21. (Pubitemid 23026675)
19. Tung TH, Chen SJ, Liu JH, et al. A community-based follow-up study on diabetic retinopathy among type 2 diabetics in Kinmen. Eur J Epidemiol. 2005;20:317-323.
20. Kohler CG, Moberg PJ, Gur RE, O'Connor MJ, Sperling MR, Doty RL. Olfactory dysfunction in schizophrenia and temporal lobe epilepsy. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:83-88. (Pubitemid 32549930)
21. Wilson RS, Yu L, Bennett DA. Odor identification and mortality in old age. Chem Senses. 2011;36:63-67.
22. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996;103:357-364. (Pubitemid 26085889)
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
24. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992. (Pubitemid 38296854)
25. Morgan CD, Nordin S, Murphy C. Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. J Clin Exp Neuropsychol. 1995;17:793-803.
26. Doty RL. Office procedures for quantitative assessment of olfactory function. Am J Rhinol. 2007;21:460-473. (Pubitemid 47360035)
27. Ekman G, Berglund B, Berglund U, Lindvall T. Perceived intensity of odor as a function of time of adaptation. Scand J Psychol. 1967;8:177-186.
28. World Health Organization. Manual of the International Statistical Classification of Disease, Injuries and Causes of Death. Geneva, Switzerland: World Health Organization; 1977:Vol. 1.
29. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. Tenth revision [ICD-10]. Geneva, Switzerland: World Health Organization; 1992.
30. Magliano D, Liew D, Pater H, et al. Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with pravastatin in ischaemic disease (LIPID) study. Aust N Z J Public Health. 2003;27:649-653. (Pubitemid 38035075)
31. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol. 2002;61:413-426. (Pubitemid 34533671)
32. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 2009;1170:730-735.
33. Hummel T, Nordin S. Olfactory disorders and their consequences for quality of life. Acta Otolaryngol. 2005;125:116-121. (Pubitemid 40293199)
34. Frasnelli J, Landis BN, Heilmann S, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004;261:411-415. (Pubitemid 39141450)
35. Mattes RD, Cowart BJ, Schiavo MA, et al. Dietary evaluation of patients with smell and/or taste disorders. Am J Clin Nutr. 1990;51:233-240.
36. Duffy VB, Backstrand JR, Ferris AM. Olfactory dysfunction and related nutritional risk in free-living, elderly women. J Am Diet Assoc. 1995;95:879-884.
37. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226:1441-1443. (Pubitemid 15161278)